BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6204566)

  • 1. In-vivo immunomodulation by isoprinosine in patients with the acquired immunodeficiency syndrome and related complexes.
    Grieco MH; Reddy MM; Manvar D; Ahuja KK; Moriarty ML
    Ann Intern Med; 1984 Aug; 101(2):206-7. PubMed ID: 6204566
    [No Abstract]   [Full Text] [Related]  

  • 2. Isoprinosine and Imuthiol, two potentially active compounds in patients with AIDS-related complex symptoms.
    Pompidou A; Delsaux MC; Telvi L; Mace B; Coutance F; Falkenrodt A; Lang JM
    Cancer Res; 1985 Sep; 45(9 Suppl):4671s-4673s. PubMed ID: 2410111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopotentiation of impaired lymphocyte functions in vitro by isoprinosine in prodromal subjects and AIDS patients.
    Tsang P; Lew F; O'Brien G; Selikoff IJ; Bekesi JG
    Int J Immunopharmacol; 1985; 7(4):511-4. PubMed ID: 2412972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism and modulation of immune dysfunction in AIDS associated syndromes.
    Bekesi JG; Tsang P; Roboz JP
    Adv Exp Med Biol; 1985; 187():141-50. PubMed ID: 2412416
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of T- and B-lymphocyte functions by isoprinosine in homosexual subjects with prodromata and in patients with acquired immune deficiency syndrome (AIDS).
    Tsang PH; Tangnavarad K; Solomon S; Bekesi JG
    J Clin Immunol; 1984 Nov; 4(6):469-78. PubMed ID: 6210301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulatory effect of isoprinosine on lymphocyte proliferative response under immunodepressive conditions.
    Portolés A; Ojeda G; Rojo JM; Portolés MP; Barasoain I
    J Immunopharmacol; 1983; 5(3):245-56. PubMed ID: 6197489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group.
    Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO; Nielsen JO
    N Engl J Med; 1990 Jun; 322(25):1757-63. PubMed ID: 1693173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action of isoprinosine on the "in vitro" activation of human lymphocytes (author's transl)].
    Morin A; Griscelli C; Daguillard F
    Ann Immunol (Paris); 1979; 130C(4):541-51. PubMed ID: 91345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of impaired B- and T-lymphocyte subsets and functions in vitro by isoprinosine in prodromal homosexuals and AIDS patients.
    Tsang PH; Zanjani MD; Warner N; Bekesi JG
    J Clin Lab Immunol; 1986 Aug; 20(4):159-65. PubMed ID: 2428980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A warning against exaggerated optimism about isoprinosine in HIV infection].
    Norrby R
    Lakartidningen; 1990 Aug; 87(32-33):2487-8. PubMed ID: 1697923
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunostimulation in the lymphadenopathy syndrome and in AIDS--Inosiplex (inosin pranobex, methisoprinol].
    Grossmann D; Behrens MI
    Onkologie; 1987 Jun; 10(3 Suppl):12-6. PubMed ID: 2443884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of immunoregulatory T-helper T-suppressor sublineages and cell-mediated immunity by isoprinosine in vitro in the early stages of AIDS.
    Tsang P; Bekesi JG
    Cancer Detect Prev Suppl; 1987; 1():611-8. PubMed ID: 2446761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of human T lymphocyte functions by isoprinosine.
    Rey A; Cupissol D; Thierry C; Esteve C; Serrou B
    Int J Immunopharmacol; 1983; 5(1):99-103. PubMed ID: 6188707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo effect of isoprinosine on interleukin-2 production, lymphocyte mitogenesis and NK activity in normal and cyclophosphamide immunosuppressed mice.
    Barasoain I; Rejas MT; Ojeda G; Portolés MP; Rojo JM
    Int J Immunopharmacol; 1986; 8(5):509-15. PubMed ID: 2428762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS therapy.
    Stephens EJ
    N Z Med J; 1986 Feb; 99(795):72-3. PubMed ID: 2418393
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunorestorative properties of isoprinosine in the treatment of patients at high risk of developing ARC or AIDS.
    Bekesi JG; Tsang PH; Wallace JI; Roboz JP
    J Clin Lab Immunol; 1987 Dec; 24(4):155-61. PubMed ID: 2452254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoprinosine abolishes the blocking factor-mediated inhibition of lymphocyte responses to Epstein-Barr virus antigens and phytohemagglutinin.
    Sundar SK; Menezes J
    Int J Immunopharmacol; 1986; 8(1):101-6. PubMed ID: 2420730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoprinosine (inosine pranobex BAN, INPX) in the treatment of AIDS and other acquired immunodeficiencies of clinical importance.
    Glasky AJ; Gordon JF
    Cancer Detect Prev Suppl; 1987; 1():597-609. PubMed ID: 2446760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoprinosine restores in vitro T lymphocyte functions of cyclophosphamide immunosuppressed mice.
    Barasoain I; Rejas MT; Portoles MP; Ojeda G; Rojo JM
    Int J Immunopharmacol; 1987; 9(4):489-96. PubMed ID: 2442109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoprinosine effects on interleukin-1 production in acquired immune deficiency syndrome (AIDS).
    Tsang KY; Donnelly RP; Galbraith GM; Fudenberg HH
    Int J Immunopharmacol; 1986; 8(4):437-41. PubMed ID: 2427461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.